FR2296430B1 - - Google Patents

Info

Publication number
FR2296430B1
FR2296430B1 FR7600016A FR7600016A FR2296430B1 FR 2296430 B1 FR2296430 B1 FR 2296430B1 FR 7600016 A FR7600016 A FR 7600016A FR 7600016 A FR7600016 A FR 7600016A FR 2296430 B1 FR2296430 B1 FR 2296430B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7600016A
Other languages
French (fr)
Other versions
FR2296430A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2296430A1 publication Critical patent/FR2296430A1/fr
Application granted granted Critical
Publication of FR2296430B1 publication Critical patent/FR2296430B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7600016A 1975-01-06 1976-01-02 Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes Granted FR2296430A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (2)

Publication Number Publication Date
FR2296430A1 FR2296430A1 (fr) 1976-07-30
FR2296430B1 true FR2296430B1 (da) 1978-11-10

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600016A Granted FR2296430A1 (fr) 1975-01-06 1976-01-02 Nouvelles preparations pharmaceutiques destinees au traitement prophylactique et therapeutique des maladies cardiaques coronariennes

Country Status (14)

Country Link
JP (1) JPS5191337A (da)
AU (1) AU499140B2 (da)
BE (1) BE837293A (da)
CA (1) CA1063516A (da)
DE (1) DE2600069A1 (da)
FR (1) FR2296430A1 (da)
GB (1) GB1510370A (da)
HK (1) HK49680A (da)
IE (1) IE42766B1 (da)
IL (1) IL48785A (da)
MY (1) MY8100159A (da)
NL (1) NL7600045A (da)
NZ (1) NZ179623A (da)
ZA (2) ZA7628B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (da) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Also Published As

Publication number Publication date
ZA7626B (en) 1976-12-29
GB1510370A (en) 1978-05-10
CA1063516A (en) 1979-10-02
AU1000276A (en) 1977-07-14
IE42766L (en) 1976-07-06
IL48785A (en) 1978-08-31
BE837293A (fr) 1976-07-05
NZ179623A (en) 1978-03-06
FR2296430A1 (fr) 1976-07-30
MY8100159A (en) 1981-12-31
JPS5191337A (da) 1976-08-10
AU499140B2 (en) 1979-04-05
ZA7628B (en) 1976-12-29
HK49680A (en) 1980-09-12
DE2600069A1 (de) 1976-07-15
IE42766B1 (en) 1980-10-08
IL48785A0 (en) 1976-03-31
NL7600045A (nl) 1976-07-08

Similar Documents

Publication Publication Date Title
FR2311692B1 (da)
JPS5194258U (da)
NO763691L (da)
FR2314502B1 (da)
FR2296430B1 (da)
JPS5758683B2 (da)
JPS51137094U (da)
JPS5625131Y2 (da)
JPS5543918B2 (da)
JPS5523672Y2 (da)
JPS547013B2 (da)
JPS51112650U (da)
JPS526630U (da)
JPS5243807U (da)
JPS5199353U (da)
JPS5280920U (da)
JPS5191145U (da)
JPS51140251U (da)
JPS5292927U (da)
JPS51128388U (da)
JPS51121411U (da)
JPS51117043U (da)
CH602501A5 (da)
CH601099A5 (da)
BG22301A1 (da)

Legal Events

Date Code Title Description
ST Notification of lapse